Litigation Details for Astellas Pharma Inc. v. Sandoz Inc. (D. Del. 2020)

Astellas Pharma Inc. v. Sandoz Inc. (D. Del. 2020)

Docket		Date Filed	2020-11-24
Court	District Court, D. Delaware	Date Terminated	2023-06-09
Cause	35:271 Patent Infringement	Assigned To	Joseph F. Bataillon
Jury Demand	Defendant	Referred To	Christopher J. Burke
Parties	AUROBINDO PHARMA USA, INC.
Patents	10,029,015; 10,036,054; 10,046,056; 6,031,003; 6,346,532; 6,562,375; 7,342,117; 7,982,049; 8,039,030; 8,772,315; 8,835,474; 9,000,041; 9,056,120; 9,279,001; RE44,872
Attorneys	Michael K. Nutter
Firms	Heyman Enerio Gattuso & Hirzel LLP
Link to Docket	External link to docket

Biologic Drugs cited in Astellas Pharma Inc. v. Sandoz Inc.

Details for Astellas Pharma Inc. v. Sandoz Inc. (D. Del. 2020)

Date Filed	Document No.	Description	Snippet	Link To Document
2020-11-24	1	Complaint	Book listed patent for Myrbetriq® Tablets, United States Patent No. 6,346,532 (“the ’532 Patent”) against… action for patent infringement of United States Patent No. 10,842,780 (“the ’780 Patent”), arising under…7,342,117 (“the ’117 Patent”), 7,982,049 (“the ’049 Patent”), 8,835,474 (“the ’474 Patent”) and RE44,872 (“the…the then-listed patents in the Orange Book for Myrbetriq® Tablets, United States Patent Nos. 7,342,117… the ’780 Patent because, inter alia, they concluded before the issuance of the ’780 Patent.	External link to document
2023-02-21	523	Redacted Document	accompanying Paragraph IV certification for U.S. Patent Nos. 7,342,117; 7,982,049; …accompanying Paragraph IV certification for U.S. Patent Nos. 7,342,117, 7,982,049, 8,835,474, and RE44,872 …, journal, patent, patent publication, certified file history of a patent or patent application, or… infringement of United States Patent No. 10,842,780 (“the ’780 Patent”) based on Sandoz’s September…infringement of United States Patent No. 10,842,780 (“the ’780 Patent”) based on Sandoz’s September	External link to document
2023-03-22	537	Redacted Document	13 – 1097:15 (Chambliss Direct); DDX 9-56. 120. A POSA would have understood that adding…THE ‘780 PATENT 1. Astellas filed the application leading to the ‘780 patent, Application…Direct); JTX-2, ‘780 Patent at 6:60-7:3 (listing 23 salts); JTX-2, ‘780 Patent at 7:50 - 9:4, 9:21-…Direct); JTX 2, ‘780 Patent at 10:44-49; DDX 9-67. 156. The ‘780 patent discloses that the…disclosed in the patent are limited to Examples 2, 8 and 9. See JTX 2, ‘780 patent at 14:45 – 17: 58	External link to document
2023-04-05	551	Redacted Document	would address the food effect (Tr. 278:3-9, 279:1-8) and achieving it using previously known formulation… ’780 Patent. And although the Patent Examiner initially raised the same concern, the Patent Office… Description ’780 Patent U.S. Patent No. 10,842,780 Tr. … and definiteness grounds. But a patent issued by the U.S. Patent and Trademark Office (“USPTO”) is…invention of the ’780 Patent. As Prof. Little explained, the invention of the ’780 Patent is the use of “	External link to document
2023-04-28	564	Exhibit 1	the systematic relationship between the two. 10:29:0015 Q. Why don't we look at one of…58:3216 patent-in-suit in this case? 13:58:3517 A. It is the '780 patent, which I understand…embody the claims of the '780 patent, in the '780 patent 14:45:49 9 itself? 14:45:4910… place within JTX-002, the '780 patent, where the patent 15:00:5617 discloses a list of hydrophilic…'780 patent and 16:46:5820 Myrbetriq is also an embodiment of the '780 patent.	External link to document